Cornerstone GPO

Cornerstone GPO

NORM Ventures’ exclusive partnership with Cardinal Health through Cornerstone Rheumatology™ GPO

NORM Ventures’ exclusive partnership with Cardinal Health through Cornerstone Rheumatology™ GPO

As one of the largest group purchasing organizations exclusively focused in Rheumatology, Cornerstone Rheumatology™ GPO offers access to competitive contracts, industry education, insights, and solutions to help rheumatology practices maintain their independence and navigate the future.

For the past seven years, Cardinal Health has been working collaboratively with NORM Ventures to support the education and advocacy mission of NORM to help community-based rheumatology practices achieve continued success.

As a Cornerstone Rheumatology™ GPO member, you’ll benefit from:

  • Access to an extensive portfolio of rheumatology medications and biosimilars 
  • A robust set of technology and practice solutions that help practices to stay focused on delivering high-quality patient care, including: Advanced practice analytics, inventory management solutions, and GPO contract dashboards.
  • Exclusive GPO member events designed to provide a forum for education, health policy updates and best practice sharing
  • Exclusive, reliable distribution through Metro Medical™ 

Explore how Cornerstone Rheumatology™ GPO can help you reach your practice goals with practical, day-to-day solutions and long-term strategic thinking.

The GPO Member Experience

Hear from fellow NORM members about their personal experiences with Cornerstone RheumatologyTM GPO.

Hear members’ stories

Rheumatology Products Requiring Dilution Reference Guide

To access the “Rheumatology Products Requiring Dilution Reference Guide” Click Here

ISMP and ASHP Guidance

ISMP and ASHP have written some guidance for handling the current fluid and drug shortages and highlight some of the safety issues with trying to substitute fluids outside of package insert instructions that may be an additional helpful resource. Access the links below.

“Small Volume Parental Solutions Shortages” – ASHP: Click Here

“Management of Drug Shortages with 0.9% Sodium Chloride, Sterile Water for Injection and EPINEPHrine” -ISMP: Click Here

Understand your state’s laws for interchangeable biosimilars

Given the robust pipeline of Humira biosimilars and additional biosimilars with rheumatology indications that are anticipated to become FDA approved starting in 2023, it’s important to understand your own state’s laws on biologic interchangeability to prepare for this change. To help your practice navigate your state’s specific guidelines and support patients with biosimilar adoption, Cardinal Health collaborated with regulatory advisors to develop a state-by-state resource to help you understand the various biosimilar interchangeability laws. You can also access additional biosimilar related articles and resources to keep you up to date on the Cardinal Health Biosimilars website

Watch NORM and Cardinal Health’s April Webinar on Supply Shortage below!

Access the Recording Here


Contact Representative

Name: Sarah Feasel – Aklilu, DCN, MEd, RD, CNSC, FAND

Title: Rheumatology National Sales Director

Email: Sarah.feasel@cardinalhealth.com

Phone: (202) 309-5199